GlaxoSmithKline PLC is shaking up how it reports Consumer Healthcare sales in a move it says will provide “greater transparency” to the main drivers of the business’ performance.
Prompted to review its reporting structure by the creation of its joint venture with Pfizer, GSK said the result of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?